Literature DB >> 7438496

Genetic susceptibility to multiple sclerosis: a linkage analysis with age-of-onset corrections.

R W Haile, S E Hodge, B R Visscher, M A Spence, R Detels, T L McAuliffe, M S Park, J P Dudley.   

Abstract

To test the hypothesis that a multiple sclerosis susceptibility (MSS) gene is linked to the HLA loci, formal linkage analysis was conducted on 40 multiplex families, 20 each from the Seattle and Los Angeles areas. The computer program LIPED was utilized. A dominant model of inheritance was assumed. Penetrance values of 0.05, 0.35, and 0.67 were entered into the analyses, and an age-of-onset correction was incorporated. The resulting lod scores were supportive of linkage at the lower penetrance levels. The maximum lod score, 2.411, at an estimated recombination fraction of 0.10 in both males and females, was generated at a penetrance value of 0.05. With a penetrance value of 0.67, the lod scores did not support linkage. Under an autosomal dominant model of inheritance, the results were supportive of linkage when the presumed penetrance of the MSS gene is low. The results also confirmed the importance of incorporating an age-of-onset correction into linkage analyses.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438496     DOI: 10.1111/j.1399-0004.1980.tb00864.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Relationship between measles HI titers and an MS susceptibility gene.

Authors:  R W Haile; B R Visscher; R Detels; N L Valdiviezo; J L Sever; D L Madden
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

2.  Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis.

Authors:  M Siger-Zajdel; K Selmaj
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

3.  An insight about genomic susceptibility & multiple sclerosis.

Authors:  Rajesh Verma; Neetu Singh
Journal:  Indian J Med Res       Date:  2017-06       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.